Standardization of an in vitro method of drug absorption

Pharmacopeial Forum

Volumn 24, Issue 2, 1998, Pages 6015-6023

  Mainprize, Terry ^a   Lee, T Grady ^a  

^a USP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0043049344     PISSN: 03634655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. USP Subcommittee on Toxicity and Cell Culture. Safety and effectiveness of pharmaceuticals-a statement on a potential approach to alternatives to animal testing. Phann Forum 1993; 19(2): 5075.
2. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research 1995; 12(3): 413-420.
3. PDA Guidance for Industry on Dissolution Testing of Immediate Release Solid Oral Dosage Forms. U.S. Department of Health and Human Services 1997.
4. Dressman J, Amidon GL, Reppas C, Shah VP. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharmaceutical Research, in press.
5. Artursson P. Cell cultures as models for drug absorption across the intestinal mucosa. Critical Reviews in Therapeutic Drug Carrier Systems 1991; 8(4):305-330.
6. Yee S. In vitro permeability across Caco-2 cells (colonie) can predict in vivo (small intestinal) absorption in manfact or myth. Pharmaceutical Research 1997; 14(6):763766.
7. Yu H, Cook TJ, Sinko PJ. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharmaceutical Research 1997; 14(6):757-762.
8. Prueksaritanont T, Gorham LM, Hochman JH, Tran LO, Vyas KP. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metabolism and Disposition 1996; 24(6):634-642.
9. Cormet E, Huneau JF, Bouras M, Carbon C, Rubinstein E, Tome D. Evidence for a passive diffusion mechanism for sparfloxacin uptake at the brush-border membrane of the human intestinal cell-line Caco-2. J Phann Sei 1997; 86(1): 33-36.
10. Hu M, Zheng L, Chen J, Liu L, Li Y, Dantzig A, Stratford R. J Drug Targeting 1995, 3(4):291-300.
11. Imanidis G, Waldner C, Mettler C, Leuenberger H. An improved diffusion cell design for determining drug transport parameters across cultured cell monolayers. J Phann Sei 1996; 85(11):l 196-1203.
12. Brayden DJ. Human intestinal epithelial cell monolayers as prescreens for oral drug delivery. Pharmaceutical News 1997; 4(1):11-15.